Negative Pressure Wound Therapy in Groin Dissection
Study Details
Study Description
Brief Summary
This study investigates the use of a negative pressure wound therapy device (PICO™, Smith & Nephew Healthcare, UK) on clean, closed surgical wounds, in patients who are undergoing inguinal lymphadenectomy for metastatic carcinoma of cutaneous origin.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Patients may develop inguinal lymph node metastases from a variety of cutaneous neoplasms. A number of factors conspire to cause a high rate of wound breakdown and other complications in this patient group. Reported rates of wound healing complications vary in the literature, but tend to affect > 40% of patients.
A new negative pressure wound therapy device is recommended for use in clean, closed surgical wounds (PICO™ system, Smith & Nephew Healthcare, UK). Patients will be randomised to receive either PICO™ system for up to seven days, or conventional dressings, and then assessed for wound healing and other outcome measures.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: PICO™ Use of PICO™ system negative pressure wound therapy device on surgical wound for up to seven days. |
Device: PICO™
Negative pressure wound therapy device for closed surgical wounds.
Other Names:
|
No Intervention: Conventional wound care Usual wound dressings will be used as comparison group. |
Outcome Measures
Primary Outcome Measures
- Time to wound healing [From date of surgery until epithelial integrity is restored at the surgical site. Assessed at least weekly until wound is healed, up to 20 weeks after surgery]
Determination of wound healing
Secondary Outcome Measures
- Wound infection As defined by Comprehensive Complication Index (CCI) [From date of surgery until wound is healed (epithelial integrity restored at surgical site), up to 20 weeks after surgery.]
As defined by Comprehensive Complication Index (CCI)
- Lymphoedema (Limb volume measurements) [From date of surgery up to one year post-operatively.]
Limb volume measurements at 3, 6, 9 and 12 months
- Need for further surgical interventions to achieve wound healing [From date of surgery until wound is healed, up to 20 weeks after surgery.]
- Scar appearance (POSAS) [From date of surgery up to one year post-operatively.]
POSAS at 3,6, 9 and 12 months
- Patient reported outcomes (qualitative interview) [From date of surgery to six months post-operatively.]
Semi-structured qualitative interviews in first week after surgery, and at 6 months after surgery.
Eligibility Criteria
Criteria
Inclusion Criteria:
- Histologically- or cytologically-proven inguinal lymph node metastases from neoplasm of cutaneous origin
Exclusion Criteria:
- inability to give informed consent for participation
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The Ulster Hospital | Belfast | Northern Ireland | United Kingdom | BT16 1RH |
Sponsors and Collaborators
- South Eastern Health and Social Care Trust
Investigators
- Study Chair: Christopher Hill, MB, South Eastern Health & Social Care Trust
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NPWT/14/1.0